These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23084855)

  • 21. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of co-purified acellular pertussis vaccines.
    Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
    Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved protocols for histamine sensitization testing of acellular pertussis vaccines.
    Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY
    Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible options for new pertussis vaccines.
    Meade BD; Plotkin SA; Locht C
    J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.
    Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
    Cell Immunol; 2004 Jan; 227(1):51-8. PubMed ID: 15051514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whither pertussis?
    Snelling TL; Waddington CS
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):145-8. PubMed ID: 25426699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis vaccines: WHO position paper - September 2015.
    Wkly Epidemiol Rec; 2015 Aug; 90(35):433-58. PubMed ID: 26320265
    [No Abstract]   [Full Text] [Related]  

  • 28. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming with whole-cell versus acellular pertussis vaccine.
    Liko J; Robison SG; Cieslak PR
    N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023
    [No Abstract]   [Full Text] [Related]  

  • 30. [Laboratory assessment problems of the efficacy of acellular pertussis vaccines].
    Gzyl A
    Przegl Epidemiol; 2004; 58(2):361-7. PubMed ID: 15517817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.
    Warfel JM; Zimmerman LI; Merkel TJ
    Clin Vaccine Immunol; 2016 Jan; 23(1):47-54. PubMed ID: 26561389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.
    Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F
    Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis vaccine trials in the 1990s.
    Lambert LC
    J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S4-9. PubMed ID: 24626871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bordetella pertussis and pertussis vaccines.
    Guiso N
    Clin Infect Dis; 2009 Nov; 49(10):1565-9. PubMed ID: 19839747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N
    Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis vaccines for adolescents and adults.
    Cherry JD
    Pediatrics; 2005 Sep; 116(3):755-6. PubMed ID: 16140719
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).
    Plans P; Toledo D; Sala MR; Camps N; Villanova M; Rodríguez R; Alvarez J; Solano R; García-Cenoz M; Barrabeig I; Godoy P; Minguell S
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2059-2067. PubMed ID: 27612470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acellular pertussis vaccine (Pa)].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):325-9. PubMed ID: 7491431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
    Gardner P
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.
    McIntyre PB; Turnbull FM; Egan AM; Burgess MA; Wolter JM; Schuerman LM
    Vaccine; 2004 Dec; 23(3):380-5. PubMed ID: 15530684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.